SFN and hepatocellular carcinoma: The results indicated that SFN overexpression in HCC tumors was significantly associated with worse OS, progression-free survival (PFS), relapse-free survival (RFS), and DFS in HCC patients (all log–rank P < 0.05; Figures 2(c), 2(d), 2(e), and 2(f)).